The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.
The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that considers the rates of association (kon ) and dissociation (koff), alongside the maximum receptor density (RT). At equilibrium, the rate of formation of the drug-receptor complex is equal to the rate of its dissociation. The magnitude of the drug's effect (E) is assumed to be proportional to the concentration of the RC complex.
For more complex dose-response relationships, the Hill equation introduces the Hill coefficient to account for the slope of the effect–concentration curve. This coefficient can greatly influence the clinical response to a drug, as it indicates the steepness of the effect–concentration relationship, with implications for the importance of dosing precision and adherence.
In summary, these models are vital for understanding how drugs interact with receptors and the subsequent effects, guiding dosing regimens and therapeutic strategies.
Once administered, a drug binds to the receptor, forming a complex that triggers a pharmacodynamic response.
Changes in this complex over time depend on association constant kon, maximum receptor density RT, drug concentration C, and dissociation constant koff.
At equilibrium, the rate of change in the drug–receptor complex is zero, simplifying the equation and defining the RC complex, with KD as the dissociation constant.
The model assumes the drug effect magnitude is proportional to the RC concentration, leading to the Emax formula. Replacing KD with EC50 yields the Emax concentration–effect equation. The resulting effect versus plasma concentration plot is curvilinear.
The Hill coefficient, ��, defines the curve’s steepness. Values above five create steep curves, where missed doses can significantly reduce therapeutic effects.
On the other hand, values less than one yield broader slopes, indicating a more gradual response.
繁體中文
